A Phase I Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer

Trial Profile

A Phase I Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Jun 2014

At a glance

  • Drugs Dovitinib (Primary) ; Everolimus
  • Indications Renal cell carcinoma
  • Focus Adverse reactions
  • Acronyms DEVELOP
  • Most Recent Events

    • 01 Feb 2014 Results presented at the 2014 Genitourinary Cancers Symposium.
    • 21 Nov 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top